Matinas BioPharma (MTNB) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts MTNB Hot Sheet
Join SI Premium – FREE
Matinas BioPharma (NYSE: MTNB) reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03).
For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Canterbury Park (CPHC) Misses Q2 EPS by 3c
- Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
